Ichthammol with zinc oxide
Ichthammol with zinc oxide is a soothing, mildly antiseptic topical preparation, often applied as a medicated bandage or paste, used for chronic lichenified or subacute eczema and other inflamed, itchy dermatoses.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Ichthammol has mild anti-inflammatory and antipruritic properties and is less keratolytic than coal tar, while zinc oxide provides a protective, astringent and mildly soothing barrier over the skin.
Prescribing in practice
- It is intended for chronic or lichenified eczema rather than acute weeping or infected lesions, on which it should be avoided.
- When used as an impregnated bandage, ensure correct application to avoid constriction, particularly over the limbs.
- Patch-test sensitivity or irritation can occur, so discontinue if the skin worsens.
Monitoring
Review the treated skin for improvement and for any irritation or sensitisation, and reassess if eczema is not settling.
Counselling the patient
- This is best for thickened, dry, itchy patches rather than weeping areas.
- If applied under a bandage, leave it in place as directed and report any tightness or discomfort.
- Continue prescribed emollients to support the skin barrier.
Evidence & guidelines
Ichthammol-containing pastes and bandages are long-established adjuncts for chronic lichenified eczema in standard dermatology practice.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD